Table 1 In vivo effect of A₁ and A_2a Adenosine Receptor Antagonists on serum insulin concentration, liver glycogen content and Homeostatic assessment model

NC

70.63 ± 1.45^a

1.65 ± 0.09^a

313 ± 10.43^a

20.87 ± 1.92^a

DBC

34.51 ± 2.34^e

3.86 ± 0.45^e

5.6 ± 0,34^f

4.24 ± 1.10^e

DBI

58.17 ± 3.26^b

1.84 ± 0,1^b

75.76 ± 11.67^b

17.83 ± 1,14^b

DCA

45.90 ± 2,18^d

2.02 ± 0.87^bc

28.73 ± 6.23^d

14.63 ± 1.39^c

DIS

49.83 ± 1.04 ^cd

2.19 ± 0.76^c

31.21 ± 5.75^d

9.68 ± 0.58^d

DPX

40.80 ± 2.02^e

2.73 ± 0.35 ^cd

13.05 ± 0.95^e

9.44 ± 0.74^d

DMF

44.96 ± 3.45^de

2.4 ± 0.98^d

19.3 ± 9.45^e

13.11 ± 1.03^c

DGT

52.75 ± 2.97^c

1.88 ± 0.23^b

50.47 ± 2.74^c

13.55 ± 1.46^c